LITS

$1.04+7.47%visit website

Lite Strategy, Inc.

Market Cap

$32M

Live price × SEC shares (Sep 22, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.05

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

0.8

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q1 FY2025 Sep 30, 2025	Q2 FY2025 Dec 31, 2025	Q3 FY2026 Mar 31, 2026	Q4 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	10	46	30	36	122
Operating income	(3,739)	(29,867)	(21,610)	(11,361)	(66,577)
Pretax income					(71,150)
Income tax					0.00
Net income	(3,639)	(30,799)	(23,694)	(13,018)	(71,150)
EPS (basic) ($)	(0.12)	(0.82)	(0.66)		(2.06)
EPS (diluted) ($)	(0.12)	(0.82)	(0.66)		(2.06)
Weighted avg. shares (basic)	29,475	37,372	35,711
Weighted avg. shares (diluted)	29,475	37,372	35,711

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-K filed Sep 28, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 60 more quarters, back to Sep 2010, with Tormere Pro.

Corporate Events (8-K)

10 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Nov 3, 2026 accepted 4:00 PM ET	3.02Unregistered equity sale	Document SEC ↗
Jul 30, 2026 accepted 8:30 AM ET	2.02Earnings release	Document SEC ↗
Jul 24, 2026 accepted 5:29 PM ET	7.01Reg FD disclosure	Document SEC ↗
May 13, 2026 accepted 8:35 AM ET	2.02Earnings release	Document SEC ↗
Feb 17, 2026 accepted 8:50 AM ET	2.02Earnings release	Document SEC ↗
Feb 12, 2026 accepted 5:10 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
Dec 30, 2025 accepted 6:00 AM ET	5.02Officer / director change	Document SEC ↗
Dec 5, 2025 accepted 4:00 PM ET	4.01Auditor change	Document SEC ↗
Nov 20, 2025 accepted 5:29 PM ET	8-K/A 5.02Officer / director change	Document SEC ↗
Nov 18, 2025 accepted 5:07 PM ET	5.02Officer / director change	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

78%

W/W +48.4pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2025-07-23	2026-10-26	Glover Nicholas	Director	Purchase	1,000	$6.00	$6K	2,000	View
2025-07-22	2026-10-26	Glover Nicholas	Director	Purchase	1,000	$6.55	$7K	1,000	View
2026-06-24	2026-06-25	Flynn James P	Director	Purchase	25.0K	$0.86	$21K	125.0K	View
2025-12-19	2025-12-22	Flynn James P	Director	Purchase	70.0K	$1.40	$98K	100.0K	View
2025-11-19	2025-11-20	Flynn James P	Director	Purchase	12.1K	$1.88	$23K	30.0K	View